Page last updated: 2024-08-17

medroxyprogesterone acetate and Colorectal Neoplasms, Hereditary Nonpolyposis

medroxyprogesterone acetate has been researched along with Colorectal Neoplasms, Hereditary Nonpolyposis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyd-Rogers, S; Broaddus, RR; Chen, LM; Conrad, P; Cornelison, T; Daniels, MS; Gershenson, DM; Loose, DS; Lu, KH; Lynch, H; Milbourne, A; Munsell, MF; Nogueras-Gonzalez, GM; Rubin, M; Yates, MS1

Trials

1 trial(s) available for medroxyprogesterone acetate and Colorectal Neoplasms, Hereditary Nonpolyposis

ArticleYear
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:8

    Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Colorectal Neoplasms, Hereditary Nonpolyposis; Contraceptives, Oral; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Medroxyprogesterone Acetate; Middle Aged; Mutation; Prognosis; Prospective Studies

2013